Search - tctmd.com

Displaying 401 - 420 of 435

Sort: Relevancy | Date

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Conference News TVT 2016

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

Michael O'Riordan

June 16, 2016

News Daily News

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

Yael L. Maxwell

June 15, 2016

News Daily News

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

Shelley Wood

June 14, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Daily News

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

Michael O'Riordan

June 07, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2016

Shelley Wood

May 31, 2016

News Daily News

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Todd Neale

April 27, 2016

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

Presentation TCT 2014

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Presenter: Igor F. Palacios, Augusto D. Pichard, Kishore J. Harjai, Malek Al-Hawwas, MD

September 16, 2014

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

News Daily News

New Adjustable Valve Shows Good First-in-Man TAVR Results

Jason Kahn

June 01, 2012

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Daily News

Local Anesthesia Feasible, Safe in Transfemoral TAVR

May 11, 2012

News Daily News

French Registry Provides Window into Real-World TAVR Use

Caitlin E. Cox

May 03, 2012

News Daily News

TAVR Suitable Even in Patients with Impaired LVEF

Caitlin E. Cox

April 19, 2012

News Daily News

VARC Definitions Help TAVR Studies Speak Common Language

April 13, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

Advertisement

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

What TAVR Needs Next . . . and What It’s Getting

Minimalist Transfemoral TAVR Reduces Costs Without Adversely Affecting Clinical Outcomes

High Mortality Following Infective Endocarditis After TAVR Warrants Better Prevention, Treatment

MitraClip for Obstructive Hypertrophic Cardiomyopathy? Small Series Raises Hopes

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Equivalent Mortality at 30 Days and 1 Year With TAVR vs Surgery, Says Large Meta-analysis

TCTMD’s Top 10 Most Popular Stories for May 2016

Study Supports Safety of Forgoing ICU Stay After TAVR in Selected Patients

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

TCT 63: Objective Assessment of Intracardiac Conduction to Guide Permanent Pacemaker Implantation Following Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

Survival After Septal Ablation for HOCM Similar to General Population

New Adjustable Valve Shows Good First-in-Man TAVR Results

TAVR Studies Tease Out Influences on Clinical Outcome

Local Anesthesia Feasible, Safe in Transfemoral TAVR

French Registry Provides Window into Real-World TAVR Use

TAVR Suitable Even in Patients with Impaired LVEF

VARC Definitions Help TAVR Studies Speak Common Language

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content